Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health | FMCG | Executive
         
Latest Jobs

Midlands and North West
21 May 2013 18:45



Northern England
21 May 2013 18:03



National Team Build
21 May 2013 18:01


Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Mark Denton
Managing Director
markd@zenopa.com
+44 1494 818 049

Testimonials
I will soon be starting in my new role and just wanted to take this opportunity to say 'thank you' to Zenopa for all your help whilst I was looking for a new role.
Sue, 2012

NHS funds 'better spent on obesity surgery than palliative care'

7 August 2012 14:24 in Medical Government/ NHS related news


A medical expert has called for more funds to be spent on surgery for obesity patients, rather than providing palliative care for the terminally ill.

Andrew de Beaux, a gastric surgeon at Edinburgh Royal Infirmary who has advised the Scottish government on obesity, questioned whether it is worth spending money on costly treatments for patients in the last weeks of their lives.

Mr de Beaux said: "Healthcare is rationing. It's trying to get a balancing act between some very expensive treatments which have very little benefit but because they have emotive benefit, we spend money on them."

He observed that treating oesophageal and gastric cancer can often cost around 20,000 to 30,000 pounds per patient, but only extends life expectancy by around six to eight weeks.

The expert also stated that obese patients do not always receive the care they may need, despite the condition causing extreme suffering, shortening life expectancy and often being a result of intrinsic factors rather than lifestyle.

NHS predictions suggest that by 2025 nearly half of all men and more than one-third of women will be obese, if current trends prevail.ADNFCR-8000103-ID-801423873-ADNFCR

Other news stories from 07/08/2012

Recent news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency



   
© Copyright 2013 Zenopa Ltd